about
TSPO-specific ligand vinpocetine exerts a neuroprotective effect by suppressing microglial inflammationVinpocetine inhibits Streptococcus pneumoniae-induced upregulation of mucin MUC5AC expression via induction of MKP-1 phosphatase in the pathogenesis of otitis mediaInhibitory effects of vinpocetine on the progression of atherosclerosis are mediated by Akt/NF-κB dependent mechanisms in apoE-/- miceCyclic nucleotide phosphodiesterases: important signaling modulators and therapeutic targets.Vinpocetine inhibits amyloid-beta induced activation of NF-κB, NLRP3 inflammasome and cytokine production in retinal pigment epithelial cellsChemocentric informatics approach to drug discovery: identification and experimental validation of selective estrogen receptor modulators as ligands of 5-hydroxytryptamine-6 receptors and as potential cognition enhancers.Clinical and molecular genetics of the phosphodiesterases (PDEs).Vinpocetine Inhibits NF-κB-Dependent Inflammation in Acute Ischemic Stroke Patients.Vinpocetine inhibits breast cancer cells growth in vitro and in vivo.Vinpocetine inhibits oligodendroglial precursor cell differentiation.Beneficial actions of the anti-inflammatory dimethyl fumarate in glioblastomasQuantitative Determination of Vinpocetine in Dietary Supplements.Therapeutic utility of phosphodiesterase type I inhibitors in neurological conditions.PDE5 Inhibitors as Potential Tools in the Treatment of Cystic Fibrosis.An update on vinpocetine: New discoveries and clinical implications.A mechanistic approach for modulation of chlorpyrifos-induced toxicity in human lymphocytes by melatonin, coenzyme Q10, and vinpocetine.Development and Validation of RP-HPLC Method for Quantitative Estimation of Vinpocetine in Pure and Pharmaceutical Dosage Forms
P2860
Q28272695-86EC5385-DD41-495C-AFDB-BD2B1E7C0A10Q30653282-567A83E8-1F44-41D6-B603-7D88D4B4AA94Q31146253-E842CE0A-1838-4295-9130-2D397D88BE7EQ34765802-3E864C8A-1329-44D0-BF04-221E4D6A535FQ35705361-AC056FF6-C38C-4E38-AB15-500BD39F5CA9Q36107446-20AB321E-CA5F-45DC-80F9-AB30E3CC80A8Q37657841-26970202-6C55-42FC-BE4E-03342EF4A026Q38374295-AEE8CAAE-D14F-4A70-9FC8-5F1B0DA56A06Q39325929-DD485609-9D88-4683-A9BB-3074C6BECA4CQ39575952-A85CEB5D-7299-487E-B272-EA2EB707557EQ41855478-0E6C032A-863C-4205-A1BC-86A790FDDA04Q41888375-764F3302-D559-4A7D-B9AF-CE3D35967BA9Q41903612-75DB9C3E-F7E9-4FF9-833C-0BC93BE5FE5AQ42325938-D5A16A5F-7261-475B-BE34-AB750DF2982EQ49567493-807CFFCD-EF22-46A7-8EB8-3DE0C576DEDEQ51665093-E62784CE-6FF7-4ED5-BA2C-DC4CE160CCFAQ58655401-2461B34C-6FA5-4212-B4C0-1D0D7FECB05C
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Vinpocetine as a potent antiinflammatory agent
@ast
Vinpocetine as a potent antiinflammatory agent
@en
Vinpocetine as a potent antiinflammatory agent
@nl
type
label
Vinpocetine as a potent antiinflammatory agent
@ast
Vinpocetine as a potent antiinflammatory agent
@en
Vinpocetine as a potent antiinflammatory agent
@nl
prefLabel
Vinpocetine as a potent antiinflammatory agent
@ast
Vinpocetine as a potent antiinflammatory agent
@en
Vinpocetine as a potent antiinflammatory agent
@nl
P2860
P356
P1476
Vinpocetine as a potent antiinflammatory agent
@en
P2093
Alexandre E Medina
P2860
P304
P356
10.1073/PNAS.1005138107
P407
P577
2010-05-21T00:00:00Z